Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Biogen Inc (NASDAQ: BIIB) closed at $182.30 down -0.57% from its previous closing price of $183.34. In other words, the price has decreased by -$0.57 from its previous closing price. On the day, 1.21 million shares were traded. BIIB stock price reached its highest trading level at $183.425 during the session, while it also had its lowest trading level at $181.31.
Ratios:
For a deeper understanding of Biogen Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.97. For the most recent quarter (mrq), Quick Ratio is recorded 1.48 and its Current Ratio is at 2.29. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.42.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on February 14, 2024, Reiterated its Buy rating but revised its target price to $300 from $305 previously.
On February 14, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $315 to $240.
UBS Downgraded its Buy to Neutral on January 24, 2024, whereas the target price for the stock was revised from $311 to $276.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 03 ’24 when Singhal Priya sold 431 shares for $204.22 per share. The transaction valued at 88,019 led to the insider holds 5,316 shares of the business.
Singhal Priya bought 431 shares of BIIB for $88,019 on Sep 03 ’24. On Apr 02 ’24, another insider, Singhal Priya, who serves as the Head of Development of the company, sold 93 shares for $213.09 each. As a result, the insider received 19,817 and left with 4,886 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIIB now has a Market Capitalization of 26554183680 and an Enterprise Value of 31304718336. As of this moment, Biogen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.96, and their Forward P/E ratio for the next fiscal year is 10.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.83. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.86 while its Price-to-Book (P/B) ratio in mrq is 1.67. Its current Enterprise Value per Revenue stands at 3.237 whereas that against EBITDA is 11.471.
Stock Price History:
Over the past 52 weeks, BIIB has reached a high of $269.43, while it has fallen to a 52-week low of $182.48. The 50-Day Moving Average of the stock is -8.68%, while the 200-Day Moving Average is calculated to be -17.21%.
Shares Statistics:
For the past three months, BIIB has traded an average of 1.06M shares per day and 1313540 over the past ten days. A total of 144.90M shares are outstanding, with a floating share count of 144.53M. Insiders hold about 0.77% of the company’s shares, while institutions hold 89.07% stake in the company. Shares short for BIIB as of 1726185600 were 3667853 with a Short Ratio of 3.47, compared to 1723680000 on 2678663. Therefore, it implies a Short% of Shares Outstanding of 3667853 and a Short% of Float of 2.8399997999999997.
